Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Interactive Cardiovascular and Thoracic Surgery|November 25, 2020
Can soluble urokinase plasminogen receptor predict outcomes after cardiac surgery?Chase T Schultz-Swarthfigure, Philip McCall, Robert Docking, et al.Free Radical Research|February 25, 2009
The mitochondria targeted antioxidant MitoQ protects against fluoroquinolone-induced oxidative stress and mitochondrial membrane damage in human Achilles tendon cellsDamon A Lowes, Carol Wallace, Michael P Murphy, et al.Journal of Pineal Research|September 1, 2022
Dose assessment of melatonin in sepsis (DAMSEL2) study: Pharmacokinetics of two doses of oral melatonin in patients with sepsisHelen F Galley, Lee Allen, Pieter J Colin, et al.Current Urology|November 23, 2023
Enfortumab vedotin and pembrolizumab as monotherapies and combination treatment in locally advanced or metastatic urothelial carcinoma: A narrative reviewMaria A Bantounou, Josip Plascevic, Lewis MacDonald, et al.Clinical and Vaccine Immunology : CVI|April 11, 2006
Production of soluble triggering receptor expressed on myeloid cells by lipopolysaccharide-stimulated human neutrophils involves de novo protein synthesisAmr M Mahdy, Damon A Lowes, Helen F Galley, et al.Journal of Pineal Research|August 24, 2017
Melatonin limits paclitaxel-induced mitochondrial dysfunction in vitro and protects against paclitaxel-induced neuropathic pain in the ratHelen F Galley, Barry McCormick, Kirsten L Wilson, et al.Frontiers in Endocrinology|March 8, 2021
Maternal Serum Melatonin Increases During Pregnancy and Falls Immediately After Delivery Implicating the Placenta as a Major Source of MelatoninHaroon Ejaz, Juliana K Figaro, Andrea M F Woolner, et al.Frontiers in Psychiatry|November 16, 2020
Melatonin Is a Feasible, Safe, and Acceptable Intervention in Doctors and Nurses Working Nightshifts: The MIDNIGHT TrialBensita M V J Thottakam, Nigel R Webster, Lee Allen, et al.Journal of Pineal Research|March 22, 2014
Melatonin as a potential therapy for sepsis: a phase I dose escalation study and an ex vivo whole blood model under conditions of sepsisHelen F Galley, Damon A Lowes, Lee Allen, et al.Free Radical Biology & Medicine|October 11, 2008
The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsisDamon A Lowes, Bensita M V Thottakam, Nigel R Webster, et al.Pageof 4